Quarterly Result29 May 2026, 10:41 pm
Gufic Biosciences: FY26 Revenue from Operations at ₹940.47 Mn
AI Summary
Gufic Biosciences Ltd announced its audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The Board of Directors approved the results in a meeting held on May 29, 2026. The company's revenue from operations for the year ended March 31, 2026, stood at ₹94,047.54 Lakhs (Standalone) and ₹94,400.66 Lakhs (Consolidated). The Board meeting commenced at 7.30 p.m. and concluded at 9.05 p.m.
Key Highlights
- Gufic Biosciences' Board approved audited financial results for FY26 on May 29, 2026.
- FY26 standalone revenue from operations reached ₹94,047.54 Lakhs.
- FY26 consolidated revenue from operations totaled ₹94,400.66 Lakhs.
- The board also approved the Independent Auditors Report and a declaration of Unmodified Opinion.